Highlights from National Lipid Association Scientific Sessions 2023 include metabolic syndrome, diabetes, HEAT assessment tool, and lifestyle interventions.
Few children receive guideline-directed cholesterol screenings, according to data from a large database study.
Investigators from Texas Tech University searched publication databases for studies evaluating risk for diabetes mellitus, hypertension, dyslipidemia, and atherosclerotic macrovascular disease in the setting of autism spectrum disorder.
The phase 3 trial included 13,970 adults who were unable to maximize or tolerate a statin and had, or were at high risk for, cardiovascular disease.
Data from the large-scale SWAN study suggest a rethinking of HDL as beneficial cholesterol for women in menopause.
Recommendations from the American College of Cardiology/American Heart Association Task Force on the management of blood cholesterol.
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
Author describes efficacy and safety information on red yeast rice in the treatment of dyslipidemia.
The risk for recurrent MACE was high among survivors of a first ever acute coronary syndrome with a substantial number of these being fatal; 34.4% had MACE within 1 year and 48.4% in 3 years.
Lifestyle behavior treatment should be the first-line treatment for patients with mildly elevated blood pressure and cholesterol.
